State Street Corp Pear Therapeutics, Inc. Transaction History

State Street Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.21 - $1.24 $4,724 - $27,897	-22,498 Reduced 2.18%	1,007,380 $261,000
Q4 2022 Feb 14, 2023	BUY	$0.99 - $2.91 $105,797 - $310,980	106,866 Added 11.58%	1,029,878 $1.22 Million
Q3 2022 Nov 15, 2022	BUY	$0.13 - $2.27 $79,427 - $1.39 Million	610,984 Added 195.81%	923,012 $1.88 Million
Q2 2022 Aug 15, 2022	BUY	$1.54 - $6.48 $359,302 - $1.51 Million	233,313 Added 296.4%	312,028 $481,000
Q1 2022 May 16, 2022	BUY	$3.67 - $7.63 $288,884 - $600,595	78,715 New	78,715 $398,000

23M

Ticker PEAR
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 138,768,992
Market Cap $1.39M
Description
Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.